High-Throughput Mapping of B Cell Receptor Sequences to Antigen Specificity
B cell receptor (BCR) sequencing is a powerful tool for interrogating immune responses to infection and vaccination, but it provides limited information about the antigen specificity of the sequenced BCRs. Here, we present LIBRA-seq (linking B cell receptor to antigen specificity through sequencing)...
Saved in:
Published in | Cell Vol. 179; no. 7; pp. 1636 - 1646.e15 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
12.12.2019
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | B cell receptor (BCR) sequencing is a powerful tool for interrogating immune responses to infection and vaccination, but it provides limited information about the antigen specificity of the sequenced BCRs. Here, we present LIBRA-seq (linking B cell receptor to antigen specificity through sequencing), a technology for high-throughput mapping of paired heavy- and light-chain BCR sequences to their cognate antigen specificities. B cells are mixed with a panel of DNA-barcoded antigens so that both the antigen barcode(s) and BCR sequence are recovered via single-cell next-generation sequencing. Using LIBRA-seq, we mapped the antigen specificity of thousands of B cells from two HIV-infected subjects. The predicted specificities were confirmed for a number of HIV- and influenza-specific antibodies, including known and novel broadly neutralizing antibodies. LIBRA-seq will be an integral tool for antibody discovery and vaccine development efforts against a wide range of antigen targets.
[Display omitted]
•LIBRA-seq: high-throughput mapping of BCR sequence to antigen specificity•Identified HIV- and influenza-specific B cells in two HIV-infected subjects•Predicted antigen reactivity for thousands of single B cells•Identified a previously unknown broadly neutralizing HIV antibody
LIBRA-seq enables high-throughput mapping of B cell receptor sequence to antigen specificity at the single-cell level. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Current Address: 10X Genomics, Inc, Pleasanton, CA, USA Author Contributions Conception of LIBRA-seq technology, I.S.; Conceptualization, I.S., A.R.S., I.S.G.; Methodology, I.S., R.S., I.S.G.; Investigation, I.S., A.R.S., K.A.P., A.A.M., R.M., S.R., C.O., N.R., A.R.G., K.J., K.J.K., J.Q., D.L., L.R., W.J.M., I.S.G.; Software, I.S., N.R.; Validation, I.S., A.R.S, N.R.; Writing – Original Draft, I.S., A.R.S..; Writing – Review & Editing, All authors; Funding Acquisition, I.S.G., D.L., L.M., P.A., M.C., B.S.G., I.S.; Resources, M.K., P.A., B.S.G., M.C., D.L., L.R., L.M., I.S.G.; Supervision, I.S.G., L.M., P.A. These authors contributed equally |
ISSN: | 0092-8674 1097-4172 1097-4172 |
DOI: | 10.1016/j.cell.2019.11.003 |